BHU Digital Repository

Seroprevalence of Hepatitis B Surface Antigen amongst Patients in Selected Hospitals in Kaduna Metropolis, Nigeria

Show simple item record

dc.contributor.author CHOCK, Jesse J.
dc.date.accessioned 2024-06-18T14:36:07Z
dc.date.available 2024-06-18T14:36:07Z
dc.date.issued 2020-12
dc.identifier.issn 5269 - 5278
dc.identifier.uri http://localhost:8080/xmlui/handle/123456789/2104
dc.description.abstract Hepatitis B virus (HBV) infection has been identified as one of the most common infectious diseases of major health concern globally. The common method for detecting hepatitis B infection is to detect the presence of hepatitis B surface antigen (HBsAg).This research work was undertaken to determine the seroprevalence and possible risk factors of hepatitis B surface antigen amongst patients in selected hospitals in Kaduna metropolis, Kaduna State, Nigeria. Two hundred (200) blood samples were collected from patients who presented themselves for HBV screening and tests were carried out for one hepatitis B virus serological marker: HBsAg using Agary HBsAg test kits. Information was obtained for risk factors using structured questionnaire. There was an increased number of females (55.5%) compared to males (44.5%) recruited for this study. An overall seroprevalence of 9.5% for HBV infection was obtained from this study. About 5.4% and 14.6%of the female and male patients respectively were HBsAg positive. There was significant association between patients with hepatitis B family history ( ᵪ 2 =25.319;p=0.001), intravenous drug use (ᵪ2=7.707;p=0.006), tribal marks/ tattoos (ᵪ2 =3.879;p=0.049) and traditional barbers (ᵪ2 =12.604;p=0.001). Other risk factors studied were not significantly associated with HBsAg seropositivity. The highest and lowest frequency of HBsAg infection was observed in age group; 35-44 years (19.2%) and 15-24 years (5.3%) respectively. The high occurrence of HBsAg in this study calls for an urgent intervention strategy that place emphasizes on the need for enlightenment and massive vaccination against HBV. en_US
dc.language.iso en en_US
dc.publisher Nigerian Journal of Microbiology en_US
dc.relation.ispartofseries Volume 34;No 2
dc.subject Hepatitis B virus en_US
dc.subject HBsAg en_US
dc.subject Risk factors en_US
dc.subject Seroprevalence en_US
dc.title Seroprevalence of Hepatitis B Surface Antigen amongst Patients in Selected Hospitals in Kaduna Metropolis, Nigeria en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search BHUDR


Advanced Search

Browse

My Account